查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014473

内视镜超音波市场：依产品、技术、应用和最终用户划分－2026-2032年全球市场预测

Endoscopy Ultrasound Market by Product, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜超音波市场价值将达到 12.1 亿美元，到 2026 年将成长至 13.1 亿美元，到 2032 年将达到 20.8 亿美元，复合年增长率为 8.01%。

主要市场统计数据
基准年 2025 12.1亿美元
预计年份：2026年 13.1亿美元
预测年份 2032 20.8亿美元
复合年增长率 (%) 8.01%

简要概述技术创新和临床实践的进展如何重新定义超音波超音波在现代胃肠、胰臟和胆道医学中的作用。

超音波（EUS）已发展成为连接内视镜和断层成像的关键诊断工具，可在复杂的胃肠道和胰胆疾病中提供高解析度视觉化和组织表征。探头设计、影像物理学和辅助技术的最新进展拓展了其适应症，提高了诊断准确性，创造了新的治疗性介入机会，并重塑了多学科临床流程。随着诊疗趋势向微创诊断和治疗转变，EUS 在分期、标靶切片检查和引导介入治疗中发挥日益重要的作用，缩短了诊断时间，并为后续的个人化治疗方案製定提供了可能。

探头创新、软体驱动的影像处理和工作流程整合如何将超音波从诊断辅助手段转变为主要手术手段。

由于探头结构的改进、软体辅助影像增强技术的应用以及介入操作从开放性手术手术室向内视镜室的转移，超音波内视镜（EUS）领域正经历着变革性的转变。前视探头、线阵探头和径向阵列探头的设计进步提高了手术的灵活性，使临床医生能够选择能够优化视野、针道轨迹并应对特定临床挑战的设备。同时，对比增强和弹性成像等影像处理技术的进步，以及3D重建技术和微型探头的出现，提高了病灶的表征能力和手术的可靠性。

评估 2025 年美国关税调整超音波设备的采购、供应商策略和临床可用性的营运和采购影响。

关税变化和贸易政策调整会对医疗器材的整个生命週期产生连锁反应，包括供应链、采购决策以及医疗保健产业的整个医疗设备生命週期。尤其是在美国，2025年实施的关税调整表改变了某些医疗设备和组件的接收成本，迫使采购团队和製造商重新评估筹资策略和合约条款。当进口关税提高时，製造商和经销商需要评估国内生产方案、区域物流策略以及与供应商的长期合约关係，以维持利润率和供应链的连续性。

从综合细分的观点阐明产品类型、临床适应症、影像技术和医疗保健环境如何相互作用，从而影响医疗设备的选择和临床使用。

细分市场分析揭示了产品、应用、技术和终端用户趋势如何相互作用，从而影响临床应用和采购偏好。在比较前瞻性、线阵和径向阵列探头类型时，临床团队会优先考虑与其手术项目相关的设备属性。具体而言，前瞻性探头因其可直接用于治疗而备受青睐，线阵探头因其可用于针引导介入和采样精度而备受青睐，而径向阵列探头则因其可用于环週解剖结构检查和初步诊断定位而备受青睐。临床医生和采购负责人在为医疗机构选择探头套装时，通常会考虑这些差异，并结合手术数量和临床部门组成进行权衡。

美洲、欧洲、中东、非洲和亚太地区的区域法规环境、偿还框架和基础设施投资如何影响先进EUS技术的采用和部署策略？

区域趋势持续影响全部区域的医疗技术应用轨迹和投资重点，每个地区都有其独特的临床驱动因素、监管路径和采购生态系统。在美洲，医疗机构在采购决策中往往优先考虑综合服务支援、全面的维护合约以及能够证明手术效率和临床疗效的证据。因此，这些机构优先选择适用于高频次三级医疗和复杂介入治疗计画的设备。支付模式和临床指南的普及程度正在影响创新技术的优先排序和规模化推广。

EUS 领域的竞争由丰富的产品系列、临床伙伴关係和售后服务模式所驱动，这些因素会影响感知价值和采购决策。

EUS生态系内的竞争动态受多种因素驱动，包括产品线广度、临床证据、售后服务以及临床伙伴关係。拥有丰富产品组合的成熟製造商通常透过全面的服务、整合的影像平台以及与大规模医院系统的现有合作关係来脱颖而出。同时，创新新参与企业则专注于模组化设计、小众影像模式以及针对特定临床需求的标靶治疗方案，从而形成一种互补而非零和的竞争环境。

为了确保 EUS 专案的成功扩展，设备团队和临床领导者需要采取切实可行的策略行动，以协调采购、培训和互通性的优先事项。

医疗设备研发、医院采购和临床专案管理领域的领导者应采取协调一致、切实可行的方法，将洞察转化为可衡量的成果。首先，应使器械选择与手术方案和培训系统相匹配，从而确保投资转化为临床柔软性和更高的治疗能力。采购团队和临床领导者之间协作制定器械规格和支援协议，有助于医疗机构更好地平衡资本支出与利用目标。

采用透明且多方面的研究途径，结合对从业人员的访谈、对临床文献的回顾、监管分析和供应链评估，得出了可靠的、基于证据的结论。

本报告的调查方法结合了定性和定量方法，旨在全面了解临床实践、技术趋势和商业性动态。主要研究包括对执业内视镜医师、介入性胃肠病学家、采购专家和临床工程师进行结构化访谈，以收集第一线人员对设备性能、培训需求和实施挑战的观点。辅助资讯包括同行评审的临床文献、监管文件、产品规格和公开的临床指南，以支持从业人员的见解并阐明该技术的成熟路径。

整合临床、技术和营运趋势，供政策制定者、临床医生和采购经理在加速负责任地部署先进的 EUS 能力时参考。

总之，内视镜超音波正处于转折点，由于技术的成熟、临床对微创诊断的需求以及采购环境的变化，其临床应用范围正在扩大。探头设计、造影和弹性成像技术以及3D成像技术的进步，提高了诊断准确性，并使内视镜室能够进行更安全、更复杂的操作。随着医疗机构和医疗设备开发商适应供应链和政策的变化，协调投资于培训、互通性和供应商关係对于技术的持续应用至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜超音波市场：依产品分类

  • 前瞻型
  • 线性阵列
  • 径向阵列

第九章 内视镜超音波市场：依技术分类

  • 造影增强
    • 微气泡剂
    • 参数量化
  • 弹性成像
    • 剪切波
    • 失真
  • 微型探针
  • 3D EUS
    • 离线重配置
    • 即时3D

第十章 内视镜超音波市场：依应用领域划分

  • 胃肠道肿瘤
  • 淋巴结分期
  • 胰臟和胆道疾病
  • 黏膜下肿瘤

第十一章 内视镜超音波市场：依最终用户划分

  • 门诊手术中心
  • 诊断中心
  • 医院

第十二章 内视镜超音波市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 内视镜超音波市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 内视镜超音波市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国内视镜超音波市场

第十六章：中国内镜超音波市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Olympus Corporation
  • Alpinion Medical Systems Co., Ltd.
  • B. Braun Melsungen AG
  • BK Medical
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Conmed Corporation
  • Cook Medical LLC
  • EndoSound, Inc.
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Huaco Healthcare Technologies Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • LeCroy
  • Medi-Globe GmbH
  • Medtronic plc
  • Mindray Medical International Limited
  • PENTAX Medical
  • Richard Wolf GmbH
  • Samsung Medison Co., Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • Teratech Corporation
Product Code: MRR-4348D129FA94

The Endoscopy Ultrasound Market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.31 billion in 2026, with a CAGR of 8.01%, reaching USD 2.08 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.21 billion
Estimated Year [2026] USD 1.31 billion
Forecast Year [2032] USD 2.08 billion
CAGR (%) 8.01%

A concise orienting overview of how technological innovation and clinical practice evolution are redefining the role of endoscopic ultrasound in contemporary gastrointestinal and pancreatobiliary care

Endoscopic ultrasound (EUS) has evolved into a pivotal modality that bridges endoscopy and cross-sectional imaging to provide high-resolution visualization and tissue characterization in complex gastrointestinal and pancreatobiliary disease. Recent advances in probe designs, imaging physics, and adjunctive technologies have expanded indications, improved diagnostic yield, and created new interventional opportunities while reshaping multidisciplinary care pathways. As the procedural landscape shifts toward minimally invasive diagnostics and therapeutics, EUS plays an increasingly central role in staging, targeted biopsy, and guided interventions that reduce time to diagnosis and enable downstream personalized treatment planning.

Clinical adoption is being driven not only by improvements in image quality and accessory compatibility but also by heightened clinician experience and evolving training paradigms. Concurrently, device manufacturers are investing in ergonomics, probe versatility, and integrated imaging suites that support real-time decision-making. Regulatory frameworks and reimbursement policies are adapting to these clinical advances, influencing deployment priorities in hospitals, diagnostic centers, and ambulatory surgery settings. Taken together, these dynamics set the stage for a period of technology-driven clinical maturation in which EUS becomes more deeply embedded in standard diagnostic algorithms and interventional toolkits.

How probe innovation, software-enabled imaging, and workflow integration are collectively transforming endoscopic ultrasound from a diagnostic adjunct into a procedural mainstay

The EUS landscape is undergoing transformative shifts driven by improvements in probe architectures, software-enabled image enhancement, and the migration of interventional capabilities from open surgical suites into endoscopy suites. Advances in forward viewing, linear array, and radial array probe designs have expanded procedural versatility, enabling clinicians to select devices that optimize field of view, needle trajectory, and access for specific clinical tasks. Simultaneously, imaging enhancements such as contrast enhancement and elastography, along with the emergence of three-dimensional reconstruction techniques and mini probes, are enhancing lesion characterization and procedural confidence.

Integration of digital workflows and compatibility with ancillary devices is accelerating the translation of EUS into complex interventions, including targeted biopsies, drainage procedures, and tumor-directed therapies. Training programs and simulation technologies are evolving in parallel to reduce the learning curve and promote safer adoption of therapeutic applications. Health systems are responding by creating multidisciplinary pathways that incorporate EUS outcomes into tumor boards and care coordination. These shifts collectively signal a move from diagnostic adjunct to procedural mainstay, driven by patient-centered demands for less invasive, higher-precision care.

Assessing the operational and procurement impacts of the United States tariff adjustments in 2025 on device sourcing, supplier strategies, and clinical availability for endoscopic ultrasound

Tariff changes and trade policy adjustments can create ripple effects across supply chains, procurement decisions, and device lifecycles within the healthcare sector. In the United States specifically, revised tariff schedules implemented in 2025 have altered landed costs for certain medical devices and components, prompting procurement teams and manufacturers to reassess sourcing strategies and contract terms. When import duties increase, manufacturers and distributors evaluate domestic production options, regional logistics strategies, and long-term supplier commitments to preserve margins and maintain supply continuity.

Procurement teams are responding by intensifying supplier diversification, seeking closer collaboration on total landed cost visibility, and exploring consignment or risk-sharing agreements to mitigate short-term price volatility. Clinical programs are increasingly focused on articulating value through outcomes and efficiencies to justify procurement choices to hospital finance and supply chain committees. Meanwhile, device developers are accelerating design-for-manufacture initiatives and localization strategies to reduce exposure to tariff-driven cost increases and to enhance control over quality and delivery timelines. These adaptive measures aim to sustain device availability for critical diagnostic and interventional procedures despite trade-related headwinds.

Integrated segmentation perspectives revealing how product typologies, clinical indications, imaging technologies, and care settings jointly influence device selection and clinical utilization

Segmentation analysis illuminates how product, application, technology, and end-user dynamics interact to shape clinical adoption and purchasing preferences. When examining products across forward viewing, linear array, and radial array probe types, clinical teams prioritize device attributes tied to the procedural portfolio: forward viewing probes are valued for direct therapeutic access, linear arrays for needle-guided interventions and sampling precision, and radial arrays for circumferential anatomic surveys and initial diagnostic orientation. Clinicians and procurement professionals often balance these differences against procedural volumes and specialty mix when selecting a probe set for an institution.

Application-driven segmentation underscores differing clinical evidence needs across gastrointestinal tumors, lymph node staging, pancreatobiliary diseases, and submucosal tumors. For each application, diagnostic sensitivity, safe therapeutic access, and integration with multidisciplinary care pathways determine clinical value. Technology segmentation reveals nuanced adoption patterns for contrast enhancement, elastography, mini probes, and three-dimensional EUS, with contrast enhancement evaluated both at the agent level and through parameter quantification, and elastography adoption influenced by distinctions between shear wave and strain techniques. Three-dimensional EUS shows divergent clinical utility depending on whether offline reconstruction or real-time three-dimensional capability is available. Finally, end-user segmentation across ambulatory surgery centers, diagnostic centers, and hospitals highlights divergent capital investment profiles, procedural throughput expectations, and staffing models that drive which device configurations and service offerings are most practical for each care setting.

How regional regulatory environments, reimbursement frameworks, and infrastructure investments across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and deployment strategies for advanced EUS technologies

Regional dynamics continue to shape adoption trajectories and investment priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific, with each geography presenting distinct clinical drivers, regulatory pathways, and procurement ecosystems. In the Americas, institutional procurement tends to emphasize integrated service support, bundled maintenance agreements, and evidence demonstrating procedural efficiency and clinical outcomes, prompting systems to prioritize devices that align with high-volume tertiary care and complex interventional programs. Payment models and clinical guideline uptake influence how innovations are prioritized and scaled.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts, reimbursement variability, and infrastructure heterogeneity create a landscape in which device manufacturers must offer flexible commercial models and robust post-market data to support adoption in diverse settings. Capacity building and training partnerships can be particularly influential in expanding advanced applications beyond major urban centers. In the Asia-Pacific region, rapid investments in hospital infrastructure, increasing specialist capacity, and a strong emphasis on minimally invasive care accelerate uptake of advanced imaging adjuncts and therapeutic EUS procedures. Regional supply chain considerations, distribution networks, and localized service capabilities further determine how quickly new technologies are translated into routine clinical practice.

Competitive dynamics driven by product portfolio depth, clinical partnerships, and aftermarket service models that determine perceived value and procurement decisions in EUS

Competitive dynamics in the EUS ecosystem are influenced by a combination of product depth, clinical evidence, aftermarket services, and collaborative clinical partnerships. Established manufacturers with broad device portfolios often differentiate through comprehensive service offerings, integrated imaging platforms, and existing relationships with large hospital systems. At the same time, innovative entrants focus on modular designs, niche imaging modalities, and targeted therapeutic solutions that address specific clinical gaps, creating a complementary competitive set rather than a zero-sum environment.

Strategic alliances between device developers, imaging software providers, and clinical centers of excellence are accelerating evidence generation and shaping perceived value. Manufacturers that invest in clinician training, simulation, and procedural workflow optimization can accelerate adoption by reducing implementation friction. Moreover, aftermarket considerations such as warranty structures, consumable compatibility, and remote diagnostics increasingly inform procurement decisions, as health systems weigh the total cost of ownership against clinical performance and operational resilience.

Practical strategic actions for device teams and clinical leaders to align procurement, training, and interoperability priorities for successful EUS program expansion

Leaders in device development, hospital procurement, and clinical program management should pursue a set of coordinated, actionable approaches to convert insights into measurable outcomes. First, align device selection with procedural portfolios and training capacity to ensure that investments deliver clinical flexibility and incremental therapeutic capability. When procurement teams and clinical leadership co-design equipment specifications and support contracts, institutions can better balance capital commitments with utilization goals.

Second, prioritize interoperability and software-enabled workflow features that reduce procedure time and enhance diagnostic confidence, while investing in clinician training and simulation to shorten adoption curves. Third, develop supplier engagement strategies that incorporate risk-sharing on consumables, service-level guarantees, and local spare-part inventories to mitigate supply chain volatility. Fourth, invest in post-procedural outcome tracking that links EUS-derived diagnoses and interventions to downstream care pathways, enabling clearer value articulation to payers and institutional stakeholders. Collectively, these actions will help organizations capture clinical and operational benefits while managing cost and implementation risk.

A transparent and triangulated research approach combining practitioner interviews, clinical literature review, regulatory analysis, and supply chain assessment to ensure robust, evidence-based conclusions

The research methodology underpinning this report combined qualitative and quantitative methods to generate a comprehensive view of clinical practice, technology trends, and commercial dynamics. Primary research included structured interviews with practicing endoscopists, interventional gastroenterologists, procurement specialists, and clinical engineers to capture firsthand perspectives on device performance, training needs, and implementation challenges. Secondary sources encompassed peer-reviewed clinical literature, regulatory filings, product specifications, and publicly available clinical guidelines to corroborate practitioner insights and to map technology maturation pathways.

Analytical processes emphasized triangulation to validate findings across multiple data points, with attention to differentiation among product types, clinical indications, imaging modalities, and end-user environments. Supply chain analysis integrated trade policy changes and distribution architectures to assess operational risk. Case studies and representative clinical scenarios were employed to illustrate real-world implications of technology choices and workflow adaptations. Throughout, methodological rigor was maintained by documenting interview protocols, inclusion criteria for secondary sources, and the analytical frameworks used to synthesize evidence into actionable insights.

Synthesis of clinical, technological, and operational trajectories that policymakers, clinicians, and procurement leaders should consider when accelerating responsible adoption of advanced EUS capabilities

In closing, endoscopic ultrasound stands at an inflection point where technological maturation, clinical demand for less invasive diagnostics, and evolving procurement environments converge to expand its clinical footprint. Advancements in probe design, contrast and elastography techniques, and three-dimensional imaging are enhancing diagnostic precision and enabling more complex interventions to be performed safely within endoscopy suites. As institutions and device developers adapt to supply chain and policy shifts, coordinated investments in training, interoperability, and supplier relationships will be critical to sustaining adoption.

Decision-makers should treat these developments as an opportunity to modernize procedural pathways, strengthen multidisciplinary collaboration, and invest in outcome measurement to demonstrate value. By doing so, clinical programs can better position themselves to deliver high-quality, efficient care while navigating commercial and operational complexities. The insights compiled here provide a practical foundation for clinicians, procurement leaders, and device developers to refine strategy and accelerate responsible adoption of advanced EUS capabilities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Ultrasound Market, by Product

  • 8.1. Forward Viewing
  • 8.2. Linear Array
  • 8.3. Radial Array

9. Endoscopy Ultrasound Market, by Technology

  • 9.1. Contrast Enhancement
    • 9.1.1. Microbubble Agents
    • 9.1.2. Parameter Quantification
  • 9.2. Elastography
    • 9.2.1. Shear Wave
    • 9.2.2. Strain
  • 9.3. Mini Probes
  • 9.4. Three D EUS
    • 9.4.1. Offline Reconstruction
    • 9.4.2. Real Time Three D

10. Endoscopy Ultrasound Market, by Application

  • 10.1. Gastrointestinal Tumors
  • 10.2. Lymph Node Staging
  • 10.3. Pancreatobiliary Diseases
  • 10.4. Submucosal Tumors

11. Endoscopy Ultrasound Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Endoscopy Ultrasound Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Endoscopy Ultrasound Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Endoscopy Ultrasound Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Endoscopy Ultrasound Market

16. China Endoscopy Ultrasound Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Olympus Corporation
  • 17.6. Alpinion Medical Systems Co., Ltd.
  • 17.7. B. Braun Melsungen AG
  • 17.8. BK Medical
  • 17.9. Boston Scientific Corporation
  • 17.10. Canon Medical Systems Corporation
  • 17.11. Conmed Corporation
  • 17.12. Cook Medical LLC
  • 17.13. EndoSound, Inc.
  • 17.14. Fujifilm Holdings Corporation
  • 17.15. Hitachi, Ltd.
  • 17.16. Huaco Healthcare Technologies Co., Ltd.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. LeCroy
  • 17.19. Medi-Globe GmbH
  • 17.20. Medtronic plc
  • 17.21. Mindray Medical International Limited
  • 17.22. PENTAX Medical
  • 17.23. Richard Wolf GmbH
  • 17.24. Samsung Medison Co., Ltd.
  • 17.25. Shenzhen Anke High-tech Co., Ltd.
  • 17.26. Siemens Healthineers AG
  • 17.27. Smith & Nephew plc
  • 17.28. SonoScape Medical Corp.
  • 17.29. Teratech Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY FORWARD VIEWING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LINEAR ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY RADIAL ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MICROBUBBLE AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PARAMETER QUANTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SHEAR WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY STRAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY MINI PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY OFFLINE RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REAL TIME THREE D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GASTROINTESTINAL TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY LYMPH NODE STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY PANCREATOBILIARY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBMUCOSAL TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ENDOSCOPY ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY CONTRAST ENHANCEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY ELASTOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY THREE D EUS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ENDOSCOPY ULTRASOUND MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)